Evidence map›Paper›PMID 32235362›Full record

ArticleTropical medicine and infectious disease2020

How Clinical Research Can Contribute to Strengthening Health Systems in Low Resource Countries.

Florent Mbo, Wilfried Mutombo, Digas Ngolo, Patrice Kabangu, Olaf Valverde Mordt, Nathalie Strub Wourgaft, Erick Mwamba

Open access · goldAbstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Florent MboHAT Platform, Drugs for Neglected Diseases initiative, Avenue Milambo, N 4, Quartier Socimat, Gombe, Kinshasa 7948, Democratic Republic of Congo.ORCID 0000-0003-0402-5400
Wilfried MutomboDrugs for Neglected Diseases initiative (DNDi), Avenue Milambo, N 4, Quartier Socimat, Gombe, Kinshasa 7948, Democratic Republic of Congo.
Digas NgoloLe Programme Nationale de Lutte contre la Trypanosomiase Humaine Africaine (PNLTHA), croisement du Boulevard Triomphal avec l'avenue de la Libération, Commune de Kasa-Vubu, Kinshasa 7948, Democratic Republic of Congo.
Patrice KabanguLe Programme Nationale de Lutte contre la Trypanosomiase Humaine Africaine (PNLTHA), croisement du Boulevard Triomphal avec l'avenue de la Libération, Commune de Kasa-Vubu, Kinshasa 7948, Democratic Republic of Congo.
Olaf Valverde MordtDrugs for Neglected Diseases initiative, 15 Chemin Louis-Dunant, 1202 Geneva, Switzerland.ORCID 0000-0002-3898-1014
Nathalie Strub WourgaftDrugs for Neglected Diseases initiative, 15 Chemin Louis-Dunant, 1202 Geneva, Switzerland.
Erick MwambaLe Programme Nationale de Lutte contre la Trypanosomiase Humaine Africaine (PNLTHA), croisement du Boulevard Triomphal avec l'avenue de la Libération, Commune de Kasa-Vubu, Kinshasa 7948, Democratic Republic of Congo.
Drugs for Neglected Diseases Initiative · CHProgramme National Multisectoriel de Lutte contre le sida · CD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical research on neglected tropical diseases is a challenge in low-resource countries, and the contribution of clinical and operational research to health system strengthening is poorly documented. Developing new, simple, safe, and effective treatments may improve the effectiveness of health systems, and conducting research directly in health structures may have an additional impact. This study describes the process of conducting clinical trials in the Democratic Republic of Congo (DRC) in compliance with international standards, and the role of the trials in strengthening health system functions, including governance, human resources, health information, provision of care, and the equipping of health services with the necessary supplies and infrastructure. We conclude that conducting clinical trials in endemic areas has not only reinforced and supported the aim of conducting high-level clinical research in endemic countries, but has also brought lasting benefits to researchers, staff, and hospitals, as well as to broader health systems, which have positive knock-on effect on patients outside of the clinical trials and their communities. Sustainability, however, remains a challenge in an underfunded health system, especially with respect to specialized equipment. Clinical research in most of sub-Saharan Africa is highly dependent on international input and external technical support; there are areas of weaknesses in trial design and documentation, as well as in data management and analysis. Financing remains a critical issue, as African investigators have difficulties in directly accessing sources of international research funding.

Indexed as

clinical researchhealth system strengtheninghuman African trypanosomiasis

Identifiers

PMID32235362
PMCPMC7345178
OpenAlexW3013969179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.